Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2174665461;65462;65463 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
N2AB2010560538;60539;60540 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
N2A1917857757;57758;57759 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
N2B1268138266;38267;38268 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
Novex-11280638641;38642;38643 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
Novex-21287338842;38843;38844 chr2:178584315;178584314;178584313chr2:179449042;179449041;179449040
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Fn3-45
  • Domain position: 88
  • Structural Position: 121
  • Q(SASA): 0.1375
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/R None None 0.999 D 0.84 0.61 0.550545596621 gnomAD-4.0.0 8.16716E-06 None None None None N None 0 0 None 0 0 None 0 0 1.17925E-05 1.4741E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.4394 ambiguous 0.3724 ambiguous -0.874 Destabilizing 0.964 D 0.751 deleterious None None None None N
S/C 0.3804 ambiguous 0.3217 benign -0.744 Destabilizing 0.135 N 0.671 neutral N 0.516201117 None None N
S/D 0.9926 likely_pathogenic 0.9877 pathogenic -1.587 Destabilizing 0.999 D 0.864 deleterious None None None None N
S/E 0.9946 likely_pathogenic 0.9925 pathogenic -1.408 Destabilizing 0.999 D 0.863 deleterious None None None None N
S/F 0.9926 likely_pathogenic 0.9901 pathogenic -0.484 Destabilizing 0.999 D 0.887 deleterious None None None None N
S/G 0.391 ambiguous 0.2513 benign -1.261 Destabilizing 0.99 D 0.815 deleterious N 0.516984358 None None N
S/H 0.9891 likely_pathogenic 0.9849 pathogenic -1.554 Destabilizing 1.0 D 0.818 deleterious None None None None N
S/I 0.9803 likely_pathogenic 0.9728 pathogenic 0.107 Stabilizing 0.997 D 0.884 deleterious D 0.550092222 None None N
S/K 0.9991 likely_pathogenic 0.9985 pathogenic -0.66 Destabilizing 0.999 D 0.851 deleterious None None None None N
S/L 0.9136 likely_pathogenic 0.8829 pathogenic 0.107 Stabilizing 0.985 D 0.877 deleterious None None None None N
S/M 0.9472 likely_pathogenic 0.9394 pathogenic -0.041 Destabilizing 1.0 D 0.823 deleterious None None None None N
S/N 0.9621 likely_pathogenic 0.9361 pathogenic -1.229 Destabilizing 0.999 D 0.857 deleterious D 0.549838733 None None N
S/P 0.9937 likely_pathogenic 0.9919 pathogenic -0.186 Destabilizing 0.999 D 0.849 deleterious None None None None N
S/Q 0.9894 likely_pathogenic 0.9855 pathogenic -0.998 Destabilizing 0.999 D 0.828 deleterious None None None None N
S/R 0.9979 likely_pathogenic 0.996 pathogenic -0.951 Destabilizing 0.999 D 0.84 deleterious D 0.537721959 None None N
S/T 0.5059 ambiguous 0.4985 ambiguous -0.907 Destabilizing 0.99 D 0.811 deleterious N 0.505170299 None None N
S/V 0.9437 likely_pathogenic 0.9271 pathogenic -0.186 Destabilizing 0.996 D 0.875 deleterious None None None None N
S/W 0.9939 likely_pathogenic 0.9918 pathogenic -0.763 Destabilizing 1.0 D 0.884 deleterious None None None None N
S/Y 0.9907 likely_pathogenic 0.9868 pathogenic -0.355 Destabilizing 0.999 D 0.891 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.